Predictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease

G Karadeniz, S Aktoğu, OF Erer, SB Kır… - Biomarkers in …, 2016 - Taylor & Francis
Aim We aimed to assess the platelet-to-lymphocyte ratio (PLR) and platelet parameters in
patients with chronic obstructive pulmonary disease (COPD). Methods A total of 60 stable …

Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients

AG El-Gazzar, MH Kamel, OKM Elbahnasy… - Expert review of …, 2020 - Taylor & Francis
Background: Chronic obstructive pulmonary disease (COPD) is the third driving reason for
death around the world and a real number of patients suffers from disease exacerbation …

[HTML][HTML] Serum biomarkers in patients with stable and acute exacerbation of chronic obstructive pulmonary disease: a comparative study

F Şahin, AF Koşar, AF Aslan, B Yiğitbaş… - Journal of medical …, 2019 - ncbi.nlm.nih.gov
Background Mean platelet volume (MPV), neutrophil-to-lymphocyte ratio (NLR) and platelet-
to-lymphocyte ratio (PLR) have all been investigated as novel inflammatory markers of …

Platelet count and platelet indices in patients with stable and acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis

A Zinellu, P Paliogiannis, E Sotgiu… - COPD: Journal of …, 2021 - Taylor & Francis
Platelets play an important role in the pathophysiology of chronic obstructive pulmonary
disease (COPD) by mediating thrombotic, inflammatory, and immune processes in the lung …

[HTML][HTML] Evaluation of platelet lymphocyte ratio and 90-day mortality in patients with acute exacerbation of chronic obstructive pulmonary disease

P Kumar, S Law, KB Sriram - Journal of thoracic disease, 2017 - ncbi.nlm.nih.gov
Background Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) have
high mortality and health care costs. The platelet to lymphocyte ratio (PLR) is a marker of …

The role of mean platelet volume in chronic obstructive pulmonary disease exacerbation

DI Agapakis, EV Massa, I Hantzis, S Maraslis… - Respiratory …, 2016 - rc.rcjournal.com
BACKGROUND: Studies have supported the correlation between mean platelet volume and
COPD. However, there are limited data on the relationship between COPD exacerbation …

Platelet indices in stable chronic obstructive pulmonary disease–association with inflammatory markers, comorbidities and therapy

I Hlapčić, A Somborac-Bačura, S Popović-Grle… - Biochemia …, 2020 - hrcak.srce.hr
Sažetak Introduction: Chronic obstructive pulmonary disease (COPD) is a complex
inflammatory condition that can affect haemostasis. This study aimed to determine …

Platelet–lymphocyte ratios: a potential marker for pulmonary tuberculosis diagnosis in COPD patients

G Chen, C Wu, Z Luo, Y Teng, S Mao - International journal of …, 2016 - Taylor & Francis
Background In recent decades, morbidity and mortality have been found to be significantly
increased in patients with chronic obstructive pulmonary disease (COPD) complicated with …

Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease

M Malerba, A Olivini, A Radaeli… - … medical research and …, 2016 - Taylor & Francis
Objective Platelet activation in COPD patients is associated with an increased risk of
cardiovascular events. We aimed at assessing the mean platelet volume (MPV), as an index …

Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease

R Wang, JY Li, Z Cao, Y Li - Respirology, 2013 - Wiley Online Library
Background and objective An increased mean platelet volume (MPV) is an early marker of
platelet activation. Activated platelets play a role in atherogenesis, inflammation and …